| |
News - March, 2010
The Rocky Mountain Blood and
Marrow Transplant Program is committed to ongoing
education in the field. We are providing the latest
treatment and research news around our program for
patients and their caregivers and physicians.
 |
03-10-2010 |
Fewer platelets could be used for some cancer and bone-marrow transplantation patients (external link)
Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.
|
|
03-04-2010 |
Targeting Leukemia Cell's Gene 'addiction' Presents New Strategy For Treatment (external link)
An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveals how leukaemia cells become 'addicted' to genes, which if targeted could prevent diseased cells from developing.
|
|
|
